1. Home
  2. EVEX vs PHAR Comparison

EVEX vs PHAR Comparison

Compare EVEX & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$2.83

Market Cap

895.1M

Sector

Industrials

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.82

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVEX
PHAR
Founded
2020
1988
Country
United States
Netherlands
Employees
198
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
895.1M
885.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EVEX
PHAR
Price
$2.83
$12.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$6.88
$38.33
AVG Volume (30 Days)
960.9K
8.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
$11,676.47
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$9.54
52 Week High
$7.70
$21.34

Technical Indicators

Market Signals
Indicator
EVEX
PHAR
Relative Strength Index (RSI) 45.82 42.87
Support Level $2.74 $11.88
Resistance Level $3.18 $13.61
Average True Range (ATR) 0.19 0.49
MACD -0.04 0.12
Stochastic Oscillator 31.19 46.62

Price Performance

Historical Comparison
EVEX
PHAR

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment, a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: